The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Penicillamine Market Research Report 2021

Global Penicillamine Market Research Report 2021

Publishing Date : Feb, 2021

License Type :
 

Report Code : 1605561

No of Pages : 93

Synopsis
Penicillamine, is a medication primarily used for the treatment of Wilson's disease. It is also used for people with kidney stones who have high urine cystine levels, rheumatoid arthritis, and various heavy metal poisonings. It is taken by mouth.

The classification of Penicillamine includes capsule and tablet. The proportion of capsule in 2019 is about 82.94%. Penicillamine is widely used for Hospitals, Drug stores and others. The most proportion of Penicillamine used for Hospitals, and the proportion in 2019 is about 49.60%. North America is the largest market, with a sales market share nearly 82.52% in 2019. Following North America, Europe is the second largest sales place with the sales market share of 9.74%. Market competition is intense. Bausch Health, Teva, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.

The global Penicillamine market was valued at US$ 85 million in 2019 and is expected to reach US$ 89 million by the end of 2026, growing at a CAGR of 1.3% during 2021-2026.

This report focuses on Penicillamine volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Penicillamine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Penicillamine Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

  • Penicillamine Capsule
  • Penicillamine Tablet

Segment by Application

  • Hospitals
  • Drugs Store
  • Others

By Region

  • North America (United States, Canada, Mexico)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, Other Regions)
  • Europe (Germany, U.K., France, Italy, Russia, Rest of Europe)
  • South America (Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, U.A.E., South Africa, Other Regions)

By Company

  • Bausch Health
  • Teva
  • Endo International
  • Ani Pharma
  • Apotex
  • Sine Pharma

Scope of the Penicillamine Market Report

Report Metric

Details

Report Name

Penicillamine Market

Market size in 2019

US$ 85 Million

The revenue forecast in 2026

US$ 89 Million

Growth Rate

CAGR of 1.3% from 2021 to 2026

Market size available for years

2019-2026

Forecast units

Value (USD) & Volume (Units)

Segments covered

Types, End-User / Applications, Companies, and Region

Report coverage

Revenue & volume forecast, company share, competitive landscape, growth factors, and trends

Geographic regions covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

Index

1 Penicillamine Market Overview
1.1 Product Overview and Scope of Penicillamine
1.2 Penicillamine Segment by Type
1.2.1 Global Penicillamine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Penicillamine Capsule
1.2.3 Penicillamine Tablet
1.3 Penicillamine Segment by Application
1.3.1 Penicillamine Sales Comparison by Application: (2021-2027)
1.3.2 Hospitals
1.3.3 Drugs Store
1.3.4 Others
1.4 Global Penicillamine Market Size Estimates and Forecasts
1.4.1 Global Penicillamine Revenue 2016-2027
1.4.2 Global Penicillamine Sales 2016-2027
1.4.3 Penicillamine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Penicillamine Market Competition by Manufacturers
2.1 Global Penicillamine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Penicillamine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Penicillamine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Penicillamine Manufacturing Sites, Area Served, Product Type
2.5 Penicillamine Market Competitive Situation and Trends
2.5.1 Penicillamine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Penicillamine Players Market Share by Revenue
2.5.3 Global Penicillamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Penicillamine Retrospective Market Scenario by Region
3.1 Global Penicillamine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Penicillamine Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Penicillamine Market Facts & Figures by Country
3.3.1 North America Penicillamine Sales by Country
3.3.2 North America Penicillamine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Penicillamine Market Facts & Figures by Country
3.4.1 Europe Penicillamine Sales by Country
3.4.2 Europe Penicillamine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Penicillamine Market Facts & Figures by Region
3.5.1 Asia Pacific Penicillamine Sales by Region
3.5.2 Asia Pacific Penicillamine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Penicillamine Market Facts & Figures by Country
3.6.1 Latin America Penicillamine Sales by Country
3.6.2 Latin America Penicillamine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Penicillamine Market Facts & Figures by Country
3.7.1 Middle East and Africa Penicillamine Sales by Country
3.7.2 Middle East and Africa Penicillamine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Penicillamine Historic Market Analysis by Type
4.1 Global Penicillamine Sales Market Share by Type (2016-2021)
4.2 Global Penicillamine Revenue Market Share by Type (2016-2021)
4.3 Global Penicillamine Price by Type (2016-2021)

5 Global Penicillamine Historic Market Analysis by Application
5.1 Global Penicillamine Sales Market Share by Application (2016-2021)
5.2 Global Penicillamine Revenue Market Share by Application (2016-2021)
5.3 Global Penicillamine Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Bausch Health
6.1.1 Bausch Health Corporation Information
6.1.2 Bausch Health Description and Business Overview
6.1.3 Bausch Health Penicillamine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Bausch Health Product Portfolio
6.1.5 Bausch Health Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Penicillamine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Teva Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Endo International
6.3.1 Endo International Corporation Information
6.3.2 Endo International Description and Business Overview
6.3.3 Endo International Penicillamine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Endo International Product Portfolio
6.3.5 Endo International Recent Developments/Updates
6.4 Ani Pharma
6.4.1 Ani Pharma Corporation Information
6.4.2 Ani Pharma Description and Business Overview
6.4.3 Ani Pharma Penicillamine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Ani Pharma Product Portfolio
6.4.5 Ani Pharma Recent Developments/Updates
6.5 Apotex
6.5.1 Apotex Corporation Information
6.5.2 Apotex Description and Business Overview
6.5.3 Apotex Penicillamine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Apotex Product Portfolio
6.5.5 Apotex Recent Developments/Updates
6.6 Sine Pharma
6.6.1 Sine Pharma Corporation Information
6.6.2 Sine Pharma Description and Business Overview
6.6.3 Sine Pharma Penicillamine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Sine Pharma Product Portfolio
6.6.5 Sine Pharma Recent Developments/Updates

7 Penicillamine Manufacturing Cost Analysis
7.1 Penicillamine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Penicillamine
7.4 Penicillamine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Penicillamine Distributors List
8.3 Penicillamine Customers

9 Penicillamine Market Dynamics
9.1 Penicillamine Industry Trends
9.2 Penicillamine Growth Drivers
9.3 Penicillamine Market Challenges
9.4 Penicillamine Market Restraints

10 Global Market Forecast
10.1 Penicillamine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Penicillamine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Penicillamine by Type (2022-2027)
10.2 Penicillamine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Penicillamine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Penicillamine by Application (2022-2027)
10.3 Penicillamine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Penicillamine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Penicillamine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Penicillamine Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Penicillamine Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Penicillamine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Penicillamine Covered in This Study
Table 5. Global Penicillamine Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Penicillamine Sales Share by Manufacturers (2016-2021)
Table 7. Global Penicillamine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Penicillamine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Penicillamine Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Penicillamine Manufacturing Sites and Area Served
Table 11. Manufacturers Penicillamine Product Type
Table 12. Global Penicillamine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Penicillamine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Penicillamine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Penicillamine Sales by Region (2016-2021) & (K Units)
Table 16. Global Penicillamine Sales Market Share by Region (2016-2021)
Table 17. Global Penicillamine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Penicillamine Sales by Country (2016-2021) & (K Units)
Table 19. North America Penicillamine Sales Market Share by Country (2016-2021)
Table 20. North America Penicillamine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Penicillamine Revenue Market Share by Country (2016-2021)
Table 22. Europe Penicillamine Sales by Country (2016-2021) & (K Units)
Table 23. Europe Penicillamine Sales Market Share by Country (2016-2021)
Table 24. Europe Penicillamine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Penicillamine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Penicillamine Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Penicillamine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Penicillamine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Penicillamine Revenue Market Share by Region (2016-2021)
Table 30. Latin America Penicillamine Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Penicillamine Sales Market Share by Country (2016-2021)
Table 32. Latin America Penicillamine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Penicillamine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Penicillamine Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Penicillamine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Penicillamine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Penicillamine Revenue Market Share by Country (2016-2021)
Table 38. Global Penicillamine Sales (K Units) by Type (2016-2021)
Table 39. Global Penicillamine Sales Market Share by Type (2016-2021)
Table 40. Global Penicillamine Revenue (Million US$) by Type (2016-2021)
Table 41. Global Penicillamine Revenue Share by Type (2016-2021)
Table 42. Global Penicillamine Price (US$/Unit) by Type (2016-2021)
Table 43. Global Penicillamine Sales (K Units) by Application (2016-2021)
Table 44. Global Penicillamine Sales Market Share by Application (2016-2021)
Table 45. Global Penicillamine Revenue (Million US$) by Application (2016-2021)
Table 46. Global Penicillamine Revenue Share by Application (2016-2021)
Table 47. Global Penicillamine Price (US$/Unit) by Application (2016-2021)
Table 48. Bausch Health Corporation Information
Table 49. Bausch Health Description and Business Overview
Table 50. Bausch Health Penicillamine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Bausch Health Penicillamine Product
Table 52. Bausch Health Recent Developments/Updates
Table 53. Teva Corporation Information
Table 54. Teva Description and Business Overview
Table 55. Teva Penicillamine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Teva Penicillamine Product
Table 57. Teva Recent Developments/Updates
Table 58. Endo International Corporation Information
Table 59. Endo International Description and Business Overview
Table 60. Endo International Penicillamine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Endo International Penicillamine Product
Table 62. Endo International Recent Developments/Updates
Table 63. Ani Pharma Corporation Information
Table 64. Ani Pharma Description and Business Overview
Table 65. Ani Pharma Penicillamine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Ani Pharma Penicillamine Product
Table 67. Ani Pharma Recent Developments/Updates
Table 68. Apotex Corporation Information
Table 69. Apotex Description and Business Overview
Table 70. Apotex Penicillamine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Apotex Penicillamine Product
Table 72. Apotex Recent Developments/Updates
Table 73. Sine Pharma Corporation Information
Table 74. Sine Pharma Description and Business Overview
Table 75. Sine Pharma Penicillamine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Sine Pharma Penicillamine Product
Table 77. Sine Pharma Recent Developments/Updates
Table 78. Production Base and Market Concentration Rate of Raw Material
Table 79. Key Suppliers of Raw Materials
Table 80. Penicillamine Distributors List
Table 81. Penicillamine Customers List
Table 82. Penicillamine Market Trends
Table 83. Penicillamine Growth Drivers
Table 84. Penicillamine Market Restraints
Table 85. Global Penicillamine Sales Forecast by Type (2022-2027) & (K Units)
Table 86. Global Penicillamine Sales Market Share Forecast by Type (2022-2027)
Table 87. Global Penicillamine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 88. Global Penicillamine Revenue Market Share Forecast by Type (2022-2027)
Table 89. Global Penicillamine Sales Forecast by Application (2022-2027) & (K Units)
Table 90. Global Penicillamine Sales Market Share Forecast by Application (2022-2027)
Table 91. Global Penicillamine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 92. Global Penicillamine Revenue Market Share Forecast by Application (2022-2027)
Table 93. Global Penicillamine Sales Forecast by Region (2022-2027) & (K Units)
Table 94. Global Penicillamine Sales Market Share Forecast by Region (2022-2027)
Table 95. Global Penicillamine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 96. Global Penicillamine Revenue Market Share Forecast by Region (2022-2027)
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Penicillamine
Figure 2. Global Penicillamine Market Share by Type in 2020 & 2027
Figure 3. Penicillamine Capsule Product Picture
Figure 4. Penicillamine Tablet Product Picture
Figure 5. Global Penicillamine Market Share by Application in 2020 & 2027
Figure 6. Hospitals
Figure 7. Drugs Store
Figure 8. Others
Figure 9. Global Penicillamine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Penicillamine Market Size 2016-2027 (US$ Million)
Figure 11. Global Penicillamine Sales 2016-2027 (K Units)
Figure 12. Global Penicillamine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Penicillamine Sales Share by Manufacturers in 2020
Figure 14. Global Penicillamine Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Penicillamine Players: Market Share by Revenue in 2020
Figure 16. Penicillamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Penicillamine Sales Market Share by Region (2016-2021)
Figure 18. Global Penicillamine Sales Market Share by Region in 2020
Figure 19. Global Penicillamine Revenue Market Share by Region (2016-2021)
Figure 20. Global Penicillamine Revenue Market Share by Region in 2020
Figure 21. U.S. Penicillamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Penicillamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Penicillamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Penicillamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Penicillamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Penicillamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Penicillamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Penicillamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Penicillamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Penicillamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Penicillamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Penicillamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Penicillamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Penicillamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Penicillamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Penicillamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Penicillamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Penicillamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Penicillamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Penicillamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Penicillamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Penicillamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Penicillamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Penicillamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Penicillamine by Type (2016-2021)
Figure 46. Sales Market Share of Penicillamine by Application (2016-2021)
Figure 47. Sales Market Share of Penicillamine by Application in 2020
Figure 48. Revenue Share of Penicillamine by Application (2016-2021)
Figure 49. Revenue Share of Penicillamine by Application in 2020
Figure 50. Manufacturing Cost Structure of Penicillamine
Figure 51. Manufacturing Process Analysis of Penicillamine
Figure 52. Penicillamine Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’